Albertsons Companies Q4 Earnings Call Highlights

• 3 Contrarian "Buy the Dip" Picks—and One Area to Avoid

Albertsons Companies (NYSE:ACI) executives told investors the grocer closed fiscal 2025 with “operational agility and beardown execution,” adjacent arsenic pharmacy-related headwinds weighed connected reported income trends successful the 4th quarter.

On the company’s 4th fourth and full-year 2025 net call, CEO Susan Morris said identical income roseate 0.7% successful Q4 and adjusted EBITDA came successful amended than expected astatine $903 million, contempt “greater than expected pharmacy headwinds.” For the afloat year, the institution reported identical income maturation of 2% and adjusted EBITDA of $3.9 billion.

→ 3 Surprising S&P 500 Outperformers of 2026

• Albertsons: Deep Value connected the Surface, Opportunity Beneath?

President and CFO Sharon McCollam said Q4 show exceeded expectations for adjusted EBITDA and adjusted EPS adjacent arsenic the manufacture faced “pharmacy dynamics that pressured reported identical sales.” She said identical-store income accrued 0.7% successful Q4, net of astir 145 ground points of pharmacy-related headwinds, which was larger than what the institution had anticipated successful its anterior outlook.

McCollam attributed the bulk of the pharmacy headwind to the Inflation Reduction Act (IRA) changes that took effect mid-quarter and broader affordability dynamics successful the sector. She said “IRA pricing and premix unit accelerated much rapidly than expected,” alongside an manufacture displacement toward a higher generic-to-brand mix. Together those factors were “an approximate 105 ground constituent headwind” to identical income successful the quarter. McCollam noted that portion the top-line interaction was significant, the borderline interaction was favorable due to the fact that generics are “structurally much accretive.”